| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VIRUSRES.2014.11.007 |
| P8608 | Fatcat ID | release_bsbuuuodovgn7hv5gdbbupfzte |
| P698 | PubMed publication ID | 25445341 |
| P5875 | ResearchGate publication ID | 269038380 |
| P50 | author | Paula Saa | Q42821520 |
| P2093 | author name string | Larisa Cervenakova | |
| P2860 | cites work | Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins | Q24564014 |
| Selective incorporation of polyanionic molecules into hamster prions | Q24596538 | ||
| Chronic wasting disease and potential transmission to humans | Q24599755 | ||
| Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey | Q24606150 | ||
| Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids | Q24614859 | ||
| Generating a prion with bacterially expressed recombinant prion protein | Q24626352 | ||
| Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions | Q24632206 | ||
| Recombinant prion protein induces a new transmissible prion disease in wild-type animals | Q24645106 | ||
| Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein | Q24655848 | ||
| Formation of native prions from minimal components in vitro | Q24676353 | ||
| Evaluation of quinacrine treatment for prion diseases | Q24682427 | ||
| De novo generation of infectious prions in vitro produces a new disease phenotype | Q27317045 | ||
| Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 | ||
| Prion diseases of humans and animals: their causes and molecular basis | Q28209943 | ||
| In situ photodegradation of incorporated polyanion does not alter prion infectivity | Q28477075 | ||
| Presence and seeding activity of pathological prion protein (PrP(TSE)) in skeletal muscles of white-tailed deer infected with chronic wasting disease | Q28477630 | ||
| Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology | Q28478072 | ||
| Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity | Q28534974 | ||
| Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport | Q36374952 | ||
| Separate mechanisms act concurrently to shed and release the prion protein from the cell | Q36436218 | ||
| Cells release prions in association with exosomes | Q36448448 | ||
| Protein misfolding cyclic amplification of prions | Q36462246 | ||
| Susceptibility of domestic cats to chronic wasting disease | Q36607404 | ||
| Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms | Q36763154 | ||
| Cell-free propagation of prion strains. | Q36936923 | ||
| Persistent propagation of variant Creutzfeldt-Jakob disease agent in murine spleen stromal cell culture with features of mesenchymal stem cells | Q36949644 | ||
| Prion protein glycosylation is not required for strain-specific neurotropism. | Q37191812 | ||
| Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization | Q37199687 | ||
| Diagnosing norovirus-associated infectious intestinal disease using viral load | Q37233578 | ||
| A 'unified theory' of prion propagation | Q37257816 | ||
| Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. | Q37339448 | ||
| Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells | Q37446544 | ||
| Design and construction of diverse mammalian prion strains | Q37453512 | ||
| In vitro studies of the transmission barrier. | Q37653878 | ||
| Photodegradation illuminates the role of polyanions in prion infectivity | Q37885650 | ||
| Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders | Q38011636 | ||
| Animal prion diseases | Q38066102 | ||
| Strain-specific role of RNAs in prion replication | Q38457828 | ||
| Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA) | Q39006845 | ||
| γ-Synuclein: seeding of α-synuclein aggregation and transmission between cells | Q39343698 | ||
| Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans | Q39604578 | ||
| Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy | Q39932784 | ||
| Packaging of prions into exosomes is associated with a novel pathway of PrP processing. | Q40163902 | ||
| Genetic informational RNA is not required for recombinant prion infectivity | Q40605366 | ||
| Scrapie strain variation and mutation | Q40729976 | ||
| Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? | Q40918121 | ||
| Cyclic amplification of prion protein misfolding | Q41091421 | ||
| Detection of infectious prions in urine | Q41371006 | ||
| Cofactor molecules induce structural transformation during infectious prion formation | Q41820269 | ||
| Infection of a cell line of mouse L fibroblasts with scrapie agent | Q41885514 | ||
| Western blot detection of scrapie-associated fibril protein in tissues outside the central nervous system from preclinical scrapie-infected mice | Q41982066 | ||
| Cell biology. A unifying role for prions in neurodegenerative diseases | Q41997625 | ||
| Y145Stop is sufficient to induce de novo generation prions using protein misfolding cyclic amplification | Q42139323 | ||
| Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization | Q42246480 | ||
| Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays | Q42271639 | ||
| Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma | Q43964856 | ||
| The risk of transmitting prion disease by blood or plasma products | Q44067465 | ||
| In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups | Q44393768 | ||
| Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent | Q44592404 | ||
| Evidence That HIV Budding in Primary Macrophages Occurs through the Exosome Release Pathway | Q44619422 | ||
| In vitro prion protein conversion in detergent-solubilized membranes | Q44781715 | ||
| Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy | Q44949376 | ||
| Bovine spongiform encephalopathy induces misfolding of alleged prion-resistant species cellular prion protein without altering its pathobiological features. | Q45074958 | ||
| Strain-dependent differences in beta-sheet conformations of abnormal prion protein | Q45282297 | ||
| Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein. | Q45826513 | ||
| Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique. | Q46002258 | ||
| Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity | Q46433690 | ||
| Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. | Q47278870 | ||
| Evidence for the multiplication of scrapie agent in cell culture | Q47676327 | ||
| Generation of genuine prion infectivity by serial PMCA. | Q47842288 | ||
| Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. | Q47843274 | ||
| Detection of PrPCWD in feces from naturally exposed Rocky Mountain elk (Cervus elaphus nelsoni) using protein misfolding cyclic amplification | Q47918912 | ||
| Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein | Q48099698 | ||
| RNA molecules stimulate prion protein conversion | Q48170423 | ||
| The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy | Q48395317 | ||
| Evolution of neuronal changes in the course of Alzheimer's disease. | Q48413398 | ||
| Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. | Q48417052 | ||
| Presymptomatic detection of prions in blood. | Q48477099 | ||
| Neural stem cell model for prion propagation | Q48513161 | ||
| In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells | Q48595899 | ||
| Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. | Q48793714 | ||
| In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie | Q48827827 | ||
| Testing times for BSE. | Q48983893 | ||
| Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. | Q49113318 | ||
| Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. | Q51790930 | ||
| Urinary excretion and blood level of prions in scrapie-infected hamsters. | Q51794689 | ||
| Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. | Q51816912 | ||
| Cell-free formation of protease-resistant prion protein. | Q53204380 | ||
| In vitro propagation of the scrapie agent. I. Transformation of mouse glia and neuroblastoma cells after infection with the mouse-adapted scrapie strain c-506. | Q53562199 | ||
| Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. | Q54068228 | ||
| Diagnosing rotavirus A associated IID: Using ELISA to identify a cut-off for real time RT-PCR. | Q54496685 | ||
| Biomedicine. An end to the prion debate? Don't count on it. | Q54502138 | ||
| CHRONIC WASTING DISEASE OF CAPTIVE MULE DEER: A SPONGIFORM ENCEPHALOPATHY | Q56210460 | ||
| Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study | Q59691327 | ||
| Normal prion protein is expressed on exosomes isolated from human plasma | Q61703733 | ||
| Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters | Q70345462 | ||
| In vitro strain adaptation of CWD prions by serial protein misfolding cyclic amplification | Q79705810 | ||
| Cellular prion protein is released on exosomes from activated platelets | Q82361268 | ||
| Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification | Q83018956 | ||
| Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanism | Q84970498 | ||
| Large‐scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain | Q85158758 | ||
| Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer's disease | Q87493200 | ||
| Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease | Q28743838 | ||
| Novel proteinaceous infectious particles cause scrapie | Q29547678 | ||
| Isolation and characterization of exosomes from cell culture supernatants and biological fluids | Q29615035 | ||
| Eight prion strains have PrP(Sc) molecules with different conformations | Q29617277 | ||
| Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice | Q29620597 | ||
| Preclinical detection of variant CJD and BSE prions in blood | Q30436588 | ||
| Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages | Q30746165 | ||
| Detection of sub-clinical CWD infection in conventional test-negative deer long after oral exposure to urine and feces from CWD+ deer | Q30946000 | ||
| Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies | Q32132961 | ||
| Prions adhere to soil minerals and remain infectious | Q33240032 | ||
| In vitro and in vivo neurotoxicity of prion protein oligomers. | Q33296885 | ||
| Accelerated high fidelity prion amplification within and across prion species barriers. | Q33366539 | ||
| Detection of CWD prions in urine and saliva of deer by transgenic mouse bioassay | Q33419079 | ||
| Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles | Q33425214 | ||
| Chronic wasting disease in bank voles: characterisation of the shortest incubation time model for prion diseases | Q33455497 | ||
| Protease-sensitive synthetic prions | Q33526987 | ||
| Detection of protease-resistant cervid prion protein in water from a CWD-endemic area | Q33576063 | ||
| Estimating prion concentration in fluids and tissues by quantitative PMCA. | Q33725459 | ||
| Protein misfolding cyclic amplification of infectious prions | Q33725480 | ||
| Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors | Q33824971 | ||
| Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease | Q33850134 | ||
| Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. | Q33907783 | ||
| Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent | Q33931107 | ||
| Relationship between conformational stability and amplification efficiency of prions | Q33994890 | ||
| Kuru in the 21st century--an acquired human prion disease with very long incubation periods | Q33997105 | ||
| Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding | Q34084209 | ||
| A novel method for preclinical detection of PrPSc in blood | Q34107715 | ||
| Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection | Q34167920 | ||
| Prions in the urine of patients with variant Creutzfeldt-Jakob disease | Q34173236 | ||
| Prion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease | Q34196340 | ||
| Experimental interspecies transmission studies of the transmissible spongiform encephalopathies to cattle: comparison to bovine spongiform encephalopathy in cattle. | Q34215267 | ||
| Prion-infected cells regulate the release of exosomes with distinct ultrastructural features | Q34286300 | ||
| Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain | Q34299382 | ||
| Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease | Q34301796 | ||
| Synthetic mammalian prions | Q34337663 | ||
| Autocatalytic self-propagation of misfolded prion protein | Q34339124 | ||
| Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier | Q34393434 | ||
| In vitro generation of infectious scrapie prions. | Q34413661 | ||
| Detection of prions in blood | Q34446509 | ||
| Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro | Q34491356 | ||
| Molecular biology of prion diseases | Q34534878 | ||
| Alzheimer's disease beta-amyloid peptides are released in association with exosomes | Q34547007 | ||
| Infectious prions in the saliva and blood of deer with chronic wasting disease | Q34571835 | ||
| Molecular model of prion transmission to humans | Q34603607 | ||
| Generation of a new form of human PrP(Sc) in vitro by interspecies transmission from cervid prions | Q34606377 | ||
| Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein | Q34641947 | ||
| Intranasal inoculation of white-tailed deer (Odocoileus virginianus) with lyophilized chronic wasting disease prion particulate complexed to montmorillonite clay | Q34720600 | ||
| Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). | Q34737100 | ||
| Cyclic amplification of protein misfolding: application to prion-related disorders and beyond | Q34750237 | ||
| The most infectious prion protein particles. | Q34805737 | ||
| Prion infection of mouse neurospheres | Q34944193 | ||
| Human prions and plasma lipoproteins | Q34983985 | ||
| Transmission of elk and deer prions to transgenic mice | Q35024303 | ||
| Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells | Q35038696 | ||
| Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein | Q35053001 | ||
| Cell-free formation of misfolded prion protein with authentic prion infectivity | Q35127478 | ||
| Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease | Q35166364 | ||
| Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death | Q35484581 | ||
| Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions | Q35585904 | ||
| Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease | Q35763138 | ||
| Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease | Q35789618 | ||
| Environmental sources of prion transmission in mule deer | Q35880452 | ||
| Rabbits are not resistant to prion infection | Q35882420 | ||
| The Trojan exosome hypothesis | Q35976953 | ||
| Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease | Q36076343 | ||
| Birth of a prion: spontaneous generation revisited | Q36211122 | ||
| Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells | Q36223171 | ||
| Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins | Q36363429 | ||
| P304 | page(s) | 47-61 | |
| P577 | publication date | 2014-11-13 | |
| P1433 | published in | Virus Research | Q15749215 |
| P1476 | title | Protein misfolding cyclic amplification (PMCA): Current status and future directions | |
| P478 | volume | 207 |
| Q40585208 | Are prions transported by plasma exosomes? |
| Q90597989 | Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases |
| Q47313313 | Detection of Prions in Blood of Cervids at the Asymptomatic Stage of Chronic Wasting Disease |
| Q40399825 | Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease |
| Q47866649 | Efficient prion disease transmission through common environmental materials |
| Q53698735 | No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases. |
| Q91967822 | PAD-Beads enrichment enhances detection of PrPSc using real-time quaking-induced conversion |
| Q64900318 | Perspective: Why Exercise Is Good and Its Lack Bad for Everything. |
| Q47232273 | Prion Strains and Transmission Barrier Phenomena |
| Q26739684 | Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting |
| Q97070651 | Scientific opinion on chronic wasting disease (II) |
| Q26776368 | Silent Prions and Covert Prion Transmission |
| Q91589712 | Use of faecal volatile organic compound analysis for ante-mortem discrimination between CWD-positive, -negative exposed, and -known negative white-tailed deer (Odocoileus virginianus) |
Search more.